There are provided inter alia compounds of formula (I)
wherein R1, R2, R3, R4a and R4b are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
There are provided inter alia compounds of formula (I) wherein R
1
, R
2
, R
3
, R
4a
and R
4b
are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.